Financials
- Market Capitalization 25.04 B
- Employee 100
- Founded 1996
- CEO N/A
- Website www.royaltypharma.com
- Headquarter United Kingdom
- FIGI N/A
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
25.25
ratio cours/chiffre d'affaires
11.02
Dividende par action
0.23
Rendement du dividende (%)
4.62
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 487 | MRNA Moderna, Inc. - Common Stock | 68.28 USD | +1.25% | -7.48% | +21.47% | +112.12% | 27.09 B USD | ||
| 518 | ROIV Roivant Sciences Ltd. - Common Shares | 34.89 USD | -0.06% | -3.33% | +13.69% | +90.55% | 25.10 B USD | ||
| 535 | INSM Insmed Incorporated - Common Stock | 109.81 USD | -0.27% | -5.69% | +15.47% | -32.24% | 23.80 B USD | ||
| 548 | INCY Incyte Corporation - Common Stock | 115.09 USD | +0.18% | -1.15% | +15.30% | +66.51% | 22.99 B USD |